News > SII, Bharat Biotech asked to submit more data for vaccine’s emergency approval

SII, Bharat Biotech asked to submit more data for vaccine’s emergency approval

The Central Drugs Standard Control Organisation's Subject Expert Committee on Wednesday asked the Serum Institute of India and Bharat Biotech to submit more data and information to get emergency use authorisation (EUA) for their Covid-19 vaccine candidates.

"After detailed deliberation, the committee recommended that the firm should present the safety and efficacy data from the ongoing Phase 3 clinical trial in the country for further consideration," the minutes of the meeting showed.